Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sleep Apnea, Obstructive 1Polycystic Ovary Syndrome 1Metabolic Syndrome 1Insulin Resistance 1Glucose Intolerance 1Breast Neoplasms 1

Interventions

Metformin 41Clomiphene 17Letrozole 6Menotropins 5Folic Acid 5drospirenone and ethinyl estradiol combination 4Liraglutide 4Chorionic Gonadotropin 4cetrorelix 3Triptorelin Pamoate 3Progesterone 3Pioglitazone 3Leuprolide 3Inositol 3Exenatide 3Ethinyl Estradiol 3Estradiol 3Vitamins 2Sperm Injections, Intracytoplasmic 2Sitagliptin Phosphate 2Simvastatin 2Gonadotropins 2Glycoprotein Hormones, alpha Subunit 2Exercise 2Escitalopram 2Cyproterone acetate, ethinyl estradiol drug combination 2Contraceptives, Oral 2Cholecalciferol 2Carnitine 2Canagliflozin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Polycystic Ovary Syndrome × Estrogens × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡